Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

Through its Genentech subsidiary, the pharmaceutical company promises to further the Triangle's bona fides as a GLP-1 hotspot ...

Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

Abivax Chief Executive Marc de Garidel dismissed as "noise" reports in the French press that pharmaceutical giant Eli Lilly ...

A case targeting alleged fraud around the safety risk of a blockbuster diabetes drug is leveraging the RICO pathway and could ...

In an interview with BioPharma Dive, the veteran biotech CEO said there remains a “significant opportunity” for young ...

Abivax ( ABVX +0.26%), a France-based biotech, saw its shares skyrocket by more than 1,740% last year after it made ...

Price target rises to $275 from Jefferies. Company partners with Lilly on $1B AI drug lab. Analysts see stock trading cheap.

Novo Nordisk oral Wegovy records 3,071 prescriptions in four days. Shares jump 6.5% as Eli Lilly oral weight loss drug awaits ...

Businesses aggressively advertising prescription drugs for weight loss have caught the eye of dietitians, policy experts, and ...

Shares of Eli Lilly came under selling pressure following an announcement by the U.S. Food and Drug Administration (FDA) ...

Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...